LIMK1 and malignant colon neoplasm: Also, patients with colon cancer having a low expression of LIMK1 and destrin had a significantly longer OS compared with the patients having high expression [80.469 ± 5.629 vs 43.322 ± 2.665, hazard ratio (HR) = 3.084, P = 0.007; 80.824 ± 5.847 vs 56.335 ± 4.304,HR = 2.617, P = 0.033].